Exclusive

Publication

Byline

Location

US Patent Issued to University of Pittsburgh-Of the Commonwealth System of Higher Education on Sept. 8 for "Targeting MYD88 gene in vitro and in vivo" (California, Pennsylvania Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,224, issued on Sept. 8, was assigned to University of Pittsburgh-Of the Commonwealth System of Higher Education (Pittsburgh). "Targeting MY... Read More


US Patent Issued to Dana-Farber Cancer Institute on Sept. 8 for "Non-canonical SWI/SNF complex and uses thereof" (Massachusetts, California Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,225, issued on Sept. 8, was assigned to Dana-Farber Cancer Institute Inc. (Boston). "Non-canonical SWI/SNF complex and uses thereof" was in... Read More


US Patent Issued to Victor Chang Cardiac Research Institute, National Cerebral and Cardiovascular Center on Sept. 8 for "KLF induced cardiomyogenesis" (Australian Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,226, issued on Sept. 8, was assigned to Victor Chang Cardiac Research Institute (Sydney) and National Cerebral and Cardiovascular Center (Os... Read More


US Patent Issued to Catalent Pharma Solutions on Sept. 8 for "Decorin compositions and use thereof" (Wisconsin Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,227, issued on Sept. 8, was assigned to Catalent Pharma Solutions LLC (Somerset, N.J.). "Decorin compositions and use thereof" was invented... Read More


US Patent Issued to RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL on Sept. 8 for "Transforming growth factor beta-resistant natural killer cells" (Ohio, Missouri Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,228, issued on Sept. 8, was assigned to RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL (Columbus, Ohio). "Transforming growth factor ... Read More


US Patent Issued to Amgen on Sept. 8 for "Engineered NRG-1 variants with improved selectivity toward ErbB4 but not against ErbB3" (California, Washington Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,229, issued on Sept. 8, was assigned to Amgen Inc. (Thousand Oaks, Calif.). "Engineered NRG-1 variants with improved selectivity toward Erb... Read More


US Patent Issued to Suzhou Forlong Biotechnology on Sept. 8 for "Development and use of interleukin 15 mutant polypeptide" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,230, issued on Sept. 8, was assigned to Suzhou Forlong Biotechnology Co. Ltd. (Jiangsu, China). "Development and use of interleukin 15 muta... Read More


US Patent Issued to SHANGHAI MINWEI BIOTECHNOLOGY on Sept. 8 for "Fusion protein having triple activity and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,231, issued on Sept. 8, was assigned to SHANGHAI MINWEI BIOTECHNOLOGY Co. LTD (Shanghai). "Fusion protein having triple activity and use th... Read More


US Patent Issued to H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE on Sept. 8 for "Artificial antigen presenting cells for genetic engineering of immune cells" (Florida Inventor)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,232, issued on Sept. 8, was assigned to H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE INC. (Tampa, Fla.). "Artificial antigen present... Read More


US Patent Issued to DiaMedica USA on Sept. 8 for "Ulinastatin polypeptides" (Minnesota, Wisconsin Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,233, issued on Sept. 8, was assigned to DiaMedica USA Inc.. "Ulinastatin polypeptides" was invented by Rick Pauls (Minneapolis), Todd Verdo... Read More